Search Results

There are 9698 results for: content related to: Temporal association as a prerequisite factor of valsartan-induced lithium toxicity

  1. Alteration of the intravenous and oral pharmacokinetics of valsartan via the concurrent use of gemfibrozil in rats

    Biopharmaceutics & Drug Disposition

    Volume 37, Issue 5, July 2016, Pages: 245–251, Seung Jun Yang, Bong Jin Kim, Lingxuan Mo and Hyo-Kyung Han

    Version of Record online : 20 JUL 2016, DOI: 10.1002/bdd.2001

  2. You have free access to this content
    Effects of Valsartan or Amlodipine Alone or in Combination on Plasma Catecholamine Levels at Rest and During Standing in Hypertensive Patients

    The Journal of Clinical Hypertension

    Volume 9, Issue 3, March 2007, Pages: 168–178, Jacques de Champlain, 1 Maria Karas, 1 Linda Assouline, 3 Reginald Nadeau, 2 A. Robert LeBlanc, 2 Bruno Dubé and 2 Pierre Larochelle 1

    Version of Record online : 20 MAR 2007, DOI: 10.1111/j.1524-6175.2007.05938.x

  3. Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension

    The Journal of Clinical Pharmacology

    Volume 51, Issue 6, June 2011, Pages: 933–942, Mr Prafulla Bhad, Dr Surya Ayalasomayajula, Dr Rajesh Karan, Dr Selene Leon, Dr Gillies-Jacques Riviere, Dr Gangadhar Sunkara and Dr Venkateswar Jarugula

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010376963

  4. You have free access to this content
    Comparative Efficacy of Aliskiren/Valsartan vs Valsartan in Nocturnal Dipper and Nondipper Hypertensive Patients: A Pooled Analysis

    The Journal of Clinical Hypertension

    Volume 14, Issue 5, May 2012, Pages: 299–306, Thomas D. Giles, 1 Thomas Alessi, 2 Das Purkayastha and 2 Dion Zappe 2

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1751-7176.2012.00608.x

  5. You have full text access to this OnlineOpen article
    Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 8, August 2015, Pages: 1773–1782, Xizhong Sui, Hongchao Wei and Dacheng Wang

    Version of Record online : 30 MAR 2015, DOI: 10.1111/jcmm.12551

  6. Monitoring lithium therapy: the impact of a quality improvement programme in the UK

    Bipolar Disorders

    Volume 15, Issue 8, December 2013, Pages: 865–875, Carol Paton, Roma Adroer and Thomas RE Barnes

    Version of Record online : 3 OCT 2013, DOI: 10.1111/bdi.12128

  7. Inhibitory Effect of Valsartan on the Intestinal Absorption and Renal Excretion of Bestatin in Rats

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 719–729, Xiaokui Huo, Qi Liu, Changyuan Wang, Qiang Meng, Huijun Sun, Jinyong Peng, Xiaochi Ma, Pengyuan Sun and Kexin Liu

    Version of Record online : 11 DEC 2013, DOI: 10.1002/jps.23805

  8. Effects of Renin-Angiotensin-Aldosterone System Blockade on Chlorhexidine Gluconate-Induced Sclerosing Encapsulated Peritonitis in Rats

    Therapeutic Apheresis and Dialysis

    Volume 16, Issue 1, February 2012, Pages: 75–80, Gülay Koçak, Alper Azak, Hesna Müzeyyen Astarcı, Bülent Huddam, Gökhan Karaca, Mevlüt Çeri, Murat Can, Mehmet Sert and Murat Duranay

    Version of Record online : 17 JAN 2012, DOI: 10.1111/j.1744-9987.2011.01031.x

  9. You have free access to this content
    Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus

    The Journal of Clinical Hypertension

    Volume 15, Issue 2, February 2013, Pages: 92–100, George L. Bakris, Suzanne Oparil, Das Purkayastha, Anthony M. Yadao, Thomas Alessi and James R. Sowers

    Version of Record online : 26 OCT 2012, DOI: 10.1111/jch.12032

  10. Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study

    Nephrology

    Volume 19, Issue 1, January 2014, Pages: 40–46, Zhiming Ye, Li Zhang, Lixia Xu, Wei Shi, Haitang Hu, Xiaofeng Shi, Weiqiang Zhong, Shuan Hou, Honghong Yan, Bin Zhang, Yunfeng Xia, Wenjian Wang, Zonglin Feng, Liping Wang and Yongzheng Liang

    Version of Record online : 17 DEC 2013, DOI: 10.1111/nep.12177

  11. You have free access to this content
    Posters

    The Journal of Clinical Hypertension

    Volume 12, Issue s1, April 2010, Pages: A18–A147,

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1751-7176.2010.00282.x

  12. Pharmacokinetics of valsartan in patients with liver disease

    Clinical Pharmacology & Therapeutics

    Volume 62, Issue 3, September 1997, Pages: 272–278, Laurence J. Brookman, Paul E. Rolan, Irving S. Benjamin, Kelvin R. Palmer, Peter J. Wyld, Peter Lloyd, Gérard Flesch, Felix Waldmeier, Antoine Sioufi and Frank Mullins

    Version of Record online : 22 SEP 1997, DOI: 10.1016/S0009-9236(97)90029-1

  13. You have full text access to this OnlineOpen article
    Valsartan independent of AT1 receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions

    Journal of Cellular and Molecular Medicine

    Volume 18, Issue 10, October 2014, Pages: 2031–2043, Yu Mi Ha, Eun Jung Park, Young Jin Kang, Sang Won Park, Hye Jung Kim and Ki Churl Chang

    Version of Record online : 11 AUG 2014, DOI: 10.1111/jcmm.12354

  14. You have full text access to this OnlineOpen article
    Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity

    Journal of Cellular and Molecular Medicine

    Volume 18, Issue 6, June 2014, Pages: 1071–1080, HaiYan Shan, Siyang Zhang, Xuelian Li, Kai yu, Xin Zhao, Xinyue Chen, Bo Jin and XiaoJuan Bai

    Version of Record online : 18 FEB 2014, DOI: 10.1111/jcmm.12251

  15. Female vulnerability for thyroid function abnormality in bipolar disorder: role of lithium treatment

    Bipolar Disorders

    Volume 16, Issue 1, February 2014, Pages: 72–82, Ayşegül Özerdem, Zeliha Tunca, Dilek Çımrın, Ceren Hıdıroğlu and Gül Ergör

    Version of Record online : 16 DEC 2013, DOI: 10.1111/bdi.12163

  16. You have free access to this content
    Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension

    The Journal of Clinical Hypertension

    Volume 13, Issue 5, May 2011, Pages: 357–365, Thomas Wells, Jeffrey Blumer, Kevin E.C. Meyers, Jose P.R. Neto, Rejane Meneses, Mieczysław Litwin, Johan Vande Walle, Susan Solar-Yohay, Victor Shi, Guangyang Han and The Valsartan Pediatric Hypertension Study Group

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1751-7176.2011.00432.x

  17. You have free access to this content
    Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results

    The Journal of Clinical Hypertension

    Volume 13, Issue 10, October 2011, Pages: 722–730, Joseph L. Izzo Jr, Howard S. Weintraub, Daniel A. Duprez, Das Purkayastha, Dion Zappe, Rita Samuel and William C. Cushman

    Version of Record online : 14 JUL 2011, DOI: 10.1111/j.1751-7176.2011.00498.x

  18. Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 1, January 2008, Pages: 85–95, Dr Yan-Ling He, Dr Monica Ligueros-Saylan, Dr Gangadhar Sunkara, Dr Ron Sabo, Dr Charlie Zhao, Dr Yibin Wang, Dr Joelle Campestrini, Dr Françoise Pommier, Dr Kiran Dole, Dr Alan Marion, Dr Willia P. Dole and Dr Dan Howard

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307880

  19. You have free access to this content
    Antihypertensive Drugs and Pharmacology

    The Journal of Clinical Hypertension

    Volume 10, Issue 5SA, May 2008, Pages: A6–A37,

    Version of Record online : 11 OCT 2011, DOI: 10.1111/j.1751-7176.2008.tb00041.x

  20. The effect of age on the pharmacokinetics of valsartan

    Biopharmaceutics & Drug Disposition

    Volume 19, Issue 4, May 1998, Pages: 237–244, A. Sioufi, F. Marfil, A. Jaouen, J. M. Cardot, J. Godbillon, F. Ezzet and P. Lloyd

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-081X(199805)19:4<237::AID-BDD100>3.0.CO;2-7